by Shana Cristoferi | May 21, 2020 | Appili Therapeutics, News
Read original here Appili Therapeutics Inc., a biopharmaceutical company focused on anti-infective drug development, today announced that Health Canada provided regulatory clearance for Appili’s Phase 2 study evaluating FUJIFILM Toyama Chemical’s (FFTC) favipiravir as...
by Shana Cristoferi | May 7, 2020 | IMV Inc., News
Read original here IMV Inc. a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines to fight against infectious diseases including COVID-19, today announced that it has completed its previously announced non-brokered...
by Shana Cristoferi | Apr 30, 2020 | IMV Inc., News
Watch here BioNova Member IMV Inc. will begin the first round of human trials for their COVID-19 vaccine this summer. The Maritime lab had a head start in the vaccine development process, building on a vaccine it developed to combat a different respiratory...
by Shana Cristoferi | Apr 28, 2020 | IMV Inc., News, Spring Loaded Technology
Read original here From producing protective equipment and hand sanitizer, to innovating medical technology, here’s how some Nova Scotia companies are changing the way they do business. In response to COVID-19, IMV initiated the development of a vaccine. The...
by Shana Cristoferi | Apr 14, 2020 | News
Read original article here Since the start of the COVID-19 pandemic, thousands of Canadian companies have answered the federal government’s call to abandon business as usual and start making face masks, ventilators and gloves. A handful of those companies are in the...
